Last updated on February 2019

Flow Diversion in Intracranial Aneurysm Treatment


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Berry Aneurysm
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Any patient with a "difficult" intracranial aneurysm in whom flow diversion is considered an appropriate if not the best but yet unproved therapeutic option by the participating clinician. Current indications may be (but not restricted to) symptomatic large or giant cavernous carotid, ophthalmic and vertebral aneurysms, fusiform intradural aneurysms, or recurring, persistent lesions after previous coiling. Aneurysm may be a recent rupture, although risks associated with antiplatelet regimens in this context should make this option rarely used

Exclusion Criteria:

  • Severe allergy, intolerance or bleeding disorder that prohibit the use of ASA or clopidogrel.
  • Absolute contraindication to endovascular treatment or anesthesia.
  • Patients unable to give informed consent.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.